Tyrosinase messenger RNA in peripheral blood is related to poor survival in patients with metastatic melanoma following interleukin-2-based immunotherapy. (Q46717044)
Jump to navigation
Jump to search
scientific article published in October 2005
Language | Label | Description | Also known as |
---|---|---|---|
English | Tyrosinase messenger RNA in peripheral blood is related to poor survival in patients with metastatic melanoma following interleukin-2-based immunotherapy. |
scientific article published in October 2005 |
Statements
Tyrosinase messenger RNA in peripheral blood is related to poor survival in patients with metastatic melanoma following interleukin-2-based immunotherapy (English)
Henrik Schmidt
Kirsten Fode
Ebba Nexo
Hans von der Maase